Clinical Trial: A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)

U.S., Aug. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07782957) titled 'A Study to Assess the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)' on Aug. 20.

Brief Summary: The aim of this study is to assess the efficacy and safety of GSK5784283 administered as add-on maintenance therapy to participants with CRSwNP.

Study Start Date: Aug. 31

Study Type: INTERVENTIONAL

Condition: Nasal Polyps

Intervention: DRUG: GSK5784283

GSK5784283 will be administered.

DRUG: Placebo

Placebo will be administered.

DRUG: Standard of Care

Standard of Care (SoC) will be administered.

Recruitment Status: NOT_YET_RECRUITIN...